Skip to main content
. 2017 Oct 6;8(54):92890–92903. doi: 10.18632/oncotarget.21641

Table 5. Risk factors affecting recurrence-free and overall survival.

Recurrence-free survival
Variable Univariate analysis Multivariate analysis*
HR 95% CI p-value HR 95% CI p-value
PD-L1 immunoreactivity (positive vs. negative) 3.125 1.448 - 6.745 0.0037 3.029 1.228 - 7.471 0.0018
Lymph node involvement (present vs. absent) 3.076 1.546 - 6.119 0.0014 3.012 1.508 - 6.018 0.016
Overall survival
Variable Univariate analysis Multivariate analysis*
HR 95% CI p-value HR 95% CI p-value
PD-L1 immunoreactivity (positive vs. negative) 2.222 0.928 - 5.32 0.07
Lymph node involvement (present vs. absent) 5.038 2.28 - 11.13 0.00006

CI, confidence interval; HR, Hazard ratio.

*Only variables significantly associated in the univariate analysis were included in the multivariate analysis.